Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its Covid-19 vaccine to the bloc in the second quarter of the year, an EU official has said.
Firm faces supply issues but striving to meet goal - EU
source J&J says it will begin deliveries to EU in second quarter J&J one-dose shot set to be approved in EU on March 11
BRUSSELS, March 9 (Reuters) - Johnson & Johnson has
told the European Union it is facing supply issues that may
complicate plans to deliver 55 million doses of its COVID-19
vaccine to the bloc in the second quarter of the year, an EU
official told Reuters.
Any delay would be a further blow to EU s vaccination plans,
which have been hampered by bumpy supplies from other vaccine
Any delay would be a further blow to EU s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.
BRUSSELS Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19…